Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, April 29, 2024
[ Mon, Apr 29th 2024
] - WOPRAI
[ Mon, Apr 29th 2024
] - WOPRAI
[ Mon, Apr 29th 2024
] - WOPRAI
[ Mon, Apr 29th 2024
] - WOPRAI
[ Mon, Apr 29th 2024
] - WOPRAI
[ Mon, Apr 29th 2024
] - WOPRAI
[ Mon, Apr 29th 2024
] - WOPRAI
[ Mon, Apr 29th 2024
] - WOPRAI
[ Mon, Apr 29th 2024
] - WOPRAI
[ Mon, Apr 29th 2024
] - WOPRAI
[ Mon, Apr 29th 2024
] - WOPRAI
[ Mon, Apr 29th 2024
] - WOPRAI
[ Mon, Apr 29th 2024
] - WOPRAI
[ Mon, Apr 29th 2024
] - WOPRAI
[ Mon, Apr 29th 2024
] - WOPRAI
[ Mon, Apr 29th 2024
] - WOPRAI
[ Mon, Apr 29th 2024
] - WOPRAI
[ Mon, Apr 29th 2024
] - WOPRAI
[ Mon, Apr 29th 2024
] - WOPRAI
[ Mon, Apr 29th 2024
] - WOPRAI
[ Mon, Apr 29th 2024
] - WOPRAI
[ Mon, Apr 29th 2024
] - WOPRAI
[ Mon, Apr 29th 2024
] - WOPRAI
[ Mon, Apr 29th 2024
] - WOPRAI
[ Mon, Apr 29th 2024
] - WOPRAI
[ Mon, Apr 29th 2024
] - WOPRAI
[ Mon, Apr 29th 2024
] - WOPRAI
[ Mon, Apr 29th 2024
] - WOPRAI
[ Mon, Apr 29th 2024
] - WOPRAI
[ Mon, Apr 29th 2024
] - WOPRAI
Graig Suvannavejh Maintained (ADVM) at Strong Buy with Decreased Target to $22 on, Apr 29th, 2024
Graig Suvannavejh of Mizuho, Maintained "Adverum Biotechnologies, Inc." (ADVM) at Strong Buy with Decreased Target from $40 to $22 on, Apr 29th, 2024.
Graig has made no other calls on ADVM in the last 4 months.
There are 2 other peers that have a rating on ADVM. Out of the 2 peers that are also analyzing ADVM, 1 agrees with Graig's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Luca Issi of "RBC Capital" Maintained at Hold with Decreased Target to $20 on, Tuesday, March 19th, 2024
This is the rating of the analyst that currently disagrees with Graig
- Daniil Gataulin of "Chardan Capital" Reiterated at Strong Buy with Increased Target to $40 on, Tuesday, March 19th, 2024
